Scientific Data Highlights Pivotal Role Of Monogram's Molecular Diagnostics In Development And Use Of New HIV Treatments

Tue, 06 Mar 2007 02:00 PM EST

... Monogram Biosciences, Inc. (Nasdaq: MGRM) today announced 20 presentations related to its portfolio of HIV diagnostic assays at the 14th Annual Conference on Retroviruses and Opportunistic Infections (CROI). [click link for full article] ...